Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02590497 : Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- Patients who will be undergoing surgery for newly-diagnosed glioblastoma

- Subtotal, gross total or biopsy patients will be eligible

- Confirmation of pathology as glioblastoma

Exclusion Criteria:

- Tissue analysis demonstrating pathology other than glioblastoma

- Patients with a contraindication to having MR imaging (e.g. pacemaker) or contrast MR
administration (e.g. hypersensitivity to gadolinium or renal insufficiency above the
institutional threshold for administration of contrast); patients with
hypersensitivity to MR contrast may be able to participate if it has been established
that premedication will mitigate the hypersensitivity reaction
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02590497      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740